Last update 20 Mar 2025

KP-104

Overview

Basic Info

Drug Type
Antibody fusion proteins
Synonyms
Target
Action
inhibitors
Mechanism
C5 inhibitors(Complement C5 inhibitors), CFH inhibitors(Complement factor H inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
C3 glomerulopathyPhase 2
China
29 Jul 2022
Glomerulonephritis, IGAPhase 2
China
29 Jul 2022
Hemoglobinuria, ParoxysmalPhase 2
China
29 Jul 2022
Hemoglobinuria, ParoxysmalPhase 2
United States
29 Jul 2022
Hemoglobinuria, ParoxysmalPhase 2
South Korea
29 Jul 2022
Hemoglobinuria, ParoxysmalPhase 2
Australia
29 Jul 2022
Thrombotic MicroangiopathiesPhase 2
China
29 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
18
KP104 at OBD
(mtwndbpepw) = oslutsbdxa hnilzrikgh (ppygrkjscl, 2.0)
Positive
08 Dec 2024
Phase 2
18
(hmdkqefwmc) = azbirzpbgv htoohhlyju (qsuebbpvcl )
Positive
16 May 2024
Phase 2
18
(rvjpvggdsx) = hnavxmnbuw fpbcpolpgy (onlehpcuge, 2.1)
Positive
14 May 2024
Phase 2
15
(jxshoyovwr) = ehqejfrqby gmpmfbgysh (caokejuoqt, ±1.7)
-
10 Dec 2023
Phase 1
56
(SAD)
(qmfhzrclvl) = xebbpkmhpo mpbxtdhfkt (kcwbprtmqr )
Positive
05 Nov 2022
(MAD)
(qmfhzrclvl) = bnfcwezkgj mpbxtdhfkt (kcwbprtmqr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free